Salt Lake City, UT, United States of America

Watson Laboratories Inc.


USPTO Granted Patents = 39

% Expired Patents = 46.2



Trademarks = 13

Forward Citations = 767

Loading Chart...
Loading Chart...

58 inventors (with patents filed for the assignee):

goldMedal John Bitner (8 out of 10 patents)

silverMedal Steven W Sanders (7 out of 11 patents)

bronzeMedal Charles D Ebert (7 out of 44 patents)

4.  Michael W Kimball (5 out of 7 patents)

5.  Anantha Rajmohan Muthusamy (3 out of 21 patents)

6.  Satishchandra P Patel (3 out of 9 patents)

7.  Sundara Lakshmi Kanniah (2 out of 8 patents)

8.  Yogesh Dhananjay Wagh (2 out of 5 patents)

9.  Nilesh Parikh (2 out of 14 patents)

10.  Vinayak T Bhalani (2 out of 6 patents)

11.  Dilip R Sanvordeker (2 out of 2 patents)

12.  Sau-Hung S Leung (2 out of 2 patents)

13.  Michael T Nordsiek (1 out of 21 patents)

14.  Kodumudi S Balaji (1 out of 12 patents)

15.  Nitin Dnyaneshwar Arote (1 out of 1 patent)


Core Competencies:
Apalutamide
Remimazolam
Selinexor
Mucoadhesive
Pharmaceutical Compositions
Transdermal Patch
Oxybutynin
Controlled Release
Chewable Dosage
Mirtazapine
Frangible Carton
Therapeutical Agent

39 patents:

Watson Laboratories Inc., based in Salt Lake City, Utah, specializes in the development and manufacturing of generic pharmaceuticals. The company focuses on delivering high-quality, affordable medications across various therapeutic areas, including pain management and cardiovascular health. With a commitment to innovation, Watson Laboratories leverages advanced research methodologies and technology to enhance drug formulation and delivery, ensuring compliance with regulatory standards while meeting the needs of healthcare providers and patients alike.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

39 Patents

#34 in Salt Lake City, UT

#100 in Utah

#8,810 in US

#17,413 in the World

Salt Lake City, UT (US)
Salt Lake City, UT, United States of America
Forward Citations = 767

58 inventors:

Please report any incorrect information to [email protected]
Loading…